Evaluation of the modified medical research council dyspnea scale for predicting hospitalization and exacerbation in japanese patients with chronic obstructive pulmonary disease

Internal Medicine

Volumn 55, Issue 1, 2016, Pages 15-24

  Natori, Hiroki ^a,b   Kawayama, Tomotaka ^a   Suetomo, Masashi ^a,c   Kinoshita, Takashi ^a   Matsuoka, Masanobu ^a   Matsunaga, Kazuko ^a   Okamoto, Masaki ^a   Hoshino, Tomoaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Ohmuta Hospital   (Japan)

^c Chikugo City Hospital   (Japan)

Author keywords

COPD; Dyspnea; Exacerbation; Hospitalization

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC AGENT;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; MORTALITY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE ASSESSMENT; SPIROMETRY; DISEASE COURSE; EPIDEMIOLOGY; EVALUATION STUDY; HOSPITALIZATION; JAPAN; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

AGED; BIOMEDICAL RESEARCH; DISEASE PROGRESSION; DYSPNEA; FEMALE; HOSPITALIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 84953285848     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.4490     Document Type: Article

References (26)

1. The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD 2014. Updated January 2014 [Internet]. [cited 2014 Nov 10]. Available from: http://www.goldcopd.org/
2. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10: 81-89, 2013.
3. Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falcó M, Muñoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 25: 515-522, 2007.
4. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124: 459-467, 2003.
5. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586, 1999.
6. Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 136: 1473-1479, 2009.
7. Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 67: 117-121, 2012.
8. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 24: 1043-1048, 2009.
9. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121: 1434-1440, 2002.
10. Suetomo M, Kawayama T, Kinoshita T, et al. COPD assessment tests scores are associated with exacerbations in Japanese patients with chronic obstructive pulmonary disease. Respir Investig 52: 288-295, 2014.
11. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543-1554, 2008.
12. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 117: 398S-401S, 2000.
13. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789, 2007.
14. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 158-164, 1999.
15. Doll H, Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics 23: 345-363, 2005.
16. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 121: 688-696, 2002.
17. Anzueto A, Cotton D, Dahl R, et al. Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med 369: 1491-1501, 2013.
18. Vestbo J, Anzueto A, Locantore N, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138, 2010.
19. Tanabe N, Muro S, Hirai T, et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183: 1653-1659, 2011.
20. Fukuchi Y, Fernandez L, Kuo HP, et al. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology 16: 825-835, 2011.
21. Ito K, Kawayama T, Shoji Y, et al. Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology 17: 940-949, 2012.
22. Menezes AM, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 145: 297-304, 2014.
23. Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 63: 951-955, 2008.
24. Yu WC, Fu SN, Tai EL, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis 8: 389-395, 2013.
25. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J 15: 13-19, 2008.
26. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest 134: 38-45, 2008.